• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国羟氯喹视网膜病变患者延迟诊断的原因及趋势

Causes and trends of late diagnosis in Korean patients with hydroxychloroquine retinopathy.

作者信息

Ahn Seong Joon, Kim Ji Hong

机构信息

Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea.

出版信息

Front Med (Lausanne). 2023 Sep 21;10:1238226. doi: 10.3389/fmed.2023.1238226. eCollection 2023.

DOI:10.3389/fmed.2023.1238226
PMID:37809332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10551622/
Abstract

INTRODUCTION

Late diagnosis of hydroxychloroquine retinopathy remains a major concern, with the potential for irreversible visual impairment. This study aimed to investigate the causes of late diagnosis in a hospital-based cohort of Korean patients with hydroxychloroquine retinopathy and assess the trend of late diagnosis from 2015 to 2022.

METHODS

Thirty-eight patients with a late diagnosis (severe stage at diagnosis) among 94 patients with hydroxychloroquine retinopathy were included in the analysis. The causes of late diagnosis were categorized as referral-related, patient-related, and screening-related factors.

RESULTS

The most prevalent cause was no or late referral to ophthalmologists, contributing to a significant gap in timely identification. Patient-related causes included delayed monitoring visits despite scheduled appointments and early-onset disease. Screening-related causes encompassed an insufficient number of sensitive tests, leading to inadequate evidence for diagnosis, and missed or wrong diagnoses by screening physicians. The proportion of late diagnoses decreased over time, indicating improvements in overall screening and detection. The decreasing proportions of screening-related causes suggest advancements in screening practices and the use of multiple sensitive tests for screening.

DISCUSSION

Efforts to further reduce late diagnoses and improve screening and diagnostic processes are necessary. Our data emphasize the importance of timely referral to ophthalmologists for early detection and management.

摘要

引言

羟氯喹视网膜病变的晚期诊断仍然是一个主要问题,存在不可逆视力损害的风险。本研究旨在调查韩国医院中羟氯喹视网膜病变患者晚期诊断的原因,并评估2015年至2022年期间晚期诊断的趋势。

方法

94例羟氯喹视网膜病变患者中有38例晚期诊断(诊断时为严重阶段)纳入分析。晚期诊断的原因分为转诊相关、患者相关和筛查相关因素。

结果

最常见的原因是未转诊或延迟转诊至眼科医生,导致及时识别方面存在显著差距。患者相关原因包括尽管有预约但监测就诊延迟以及疾病早发。筛查相关原因包括敏感检查数量不足,导致诊断证据不足,以及筛查医生漏诊或误诊。晚期诊断的比例随时间下降,表明总体筛查和检测有所改善。筛查相关原因比例的下降表明筛查实践有所进步,且使用了多种敏感检查进行筛查。

讨论

进一步减少晚期诊断并改善筛查和诊断流程的努力是必要的。我们的数据强调了及时转诊至眼科医生以进行早期检测和管理的重要性。

相似文献

1
Causes and trends of late diagnosis in Korean patients with hydroxychloroquine retinopathy.韩国羟氯喹视网膜病变患者延迟诊断的原因及趋势
Front Med (Lausanne). 2023 Sep 21;10:1238226. doi: 10.3389/fmed.2023.1238226. eCollection 2023.
2
Effect of disease stage on progression of hydroxychloroquine retinopathy.疾病阶段对羟氯喹视网膜病变进展的影响。
JAMA Ophthalmol. 2014 Sep;132(9):1105-12. doi: 10.1001/jamaophthalmol.2014.1099.
3
Ocular toxicity of hydroxychloroquine.羟氯喹的眼部毒性。
Hong Kong Med J. 2006 Aug;12(4):294-304.
4
Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.提高接受羟氯喹治疗的儿科风湿病患者的眼部筛查实践。
Lupus. 2021 Feb;30(2):269-279. doi: 10.1177/0961203320979038. Epub 2020 Dec 13.
5
Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.台湾长期服用羟氯喹患者的当前筛查实践:一项基于全国人群的队列研究。
Medicine (Baltimore). 2019 Apr;98(14):e15122. doi: 10.1097/MD.0000000000015122.
6
A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom.一项针对英国医院眼科服务中羟氯喹视网膜病变就诊的全国性调查。
Eye (Lond). 2023 Jul;37(10):2082-2088. doi: 10.1038/s41433-022-02291-0. Epub 2022 Nov 15.
7
Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.韩国风湿性疾病患者中羟氯喹视网膜病变的发生率及临床特征
J Korean Med Sci. 2017 Mar;32(3):522-527. doi: 10.3346/jkms.2017.32.3.522.
8
Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.使用 OCT 视网膜厚度偏差图进行羟氯喹视网膜病变筛查。
Ophthalmology. 2021 Jan;128(1):110-119. doi: 10.1016/j.ophtha.2020.06.021. Epub 2020 Jun 16.
9
Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.羟氯喹相关性视网膜病变视野筛查中红色靶标和图形偏差图的价值。
JAMA Ophthalmol. 2013 Apr;131(4):476-80. doi: 10.1001/jamaophthalmol.2013.1404.
10
Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.心周型羟氯喹性视网膜病变的长期进展。
Ophthalmology. 2021 Jun;128(6):889-898. doi: 10.1016/j.ophtha.2020.10.029. Epub 2020 Oct 28.

本文引用的文献

1
Practice Patterns of Screening for Hydroxychloroquine Retinopathy in South Korea.韩国羟氯喹视网膜病变筛查的实践模式。
JAMA Netw Open. 2023 May 1;6(5):e2314816. doi: 10.1001/jamanetworkopen.2023.14816.
2
Novel imaging techniques for hydroxychloroquine retinopathy.羟氯喹视网膜病变的新型成像技术。
Front Med (Lausanne). 2022 Oct 13;9:1026934. doi: 10.3389/fmed.2022.1026934. eCollection 2022.
3
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thicknesses in Hydroxychloroquine Retinopathy.羟氯喹视网膜病变中黄斑神经节细胞复合体及视乳头周围视网膜神经纤维层厚度
Am J Ophthalmol. 2023 Jan;245:70-80. doi: 10.1016/j.ajo.2022.07.028. Epub 2022 Aug 11.
4
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.美国风湿病学会、美国皮肤病学会、风湿病皮肤病学会和美国眼科学会 2020 年关于羟氯喹视网膜毒性的联合声明
Arthritis Rheumatol. 2021 Jun;73(6):908-911. doi: 10.1002/art.41683. Epub 2021 Apr 26.
5
ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update).国际临床多焦视网膜电图学会标准(2021 年更新版)。
Doc Ophthalmol. 2021 Feb;142(1):5-16. doi: 10.1007/s10633-020-09812-w. Epub 2021 Jan 25.
6
Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.心周型羟氯喹性视网膜病变的长期进展。
Ophthalmology. 2021 Jun;128(6):889-898. doi: 10.1016/j.ophtha.2020.10.029. Epub 2020 Oct 28.
7
Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.羟氯喹视网膜病变的超广角眼底自发荧光评估:视网膜病变的周边表现。
Am J Ophthalmol. 2020 Jan;209:35-44. doi: 10.1016/j.ajo.2019.09.008. Epub 2019 Sep 14.
8
Classification and Guidelines for Widefield Imaging: Recommendations from the International Widefield Imaging Study Group.宽视野成像的分类与指南:国际宽视野成像研究组的建议
Ophthalmol Retina. 2019 Oct;3(10):843-849. doi: 10.1016/j.oret.2019.05.007. Epub 2019 May 13.
9
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.2019 年更新版的 EULAR 系统性红斑狼疮治疗建议。
Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.
10
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.羟氯喹治疗类风湿关节炎的临床和结构疗效:系统评价。
Arthritis Care Res (Hoboken). 2020 Jan;72(1):36-40. doi: 10.1002/acr.23826.